fda bpc-157 category 2 bulk drug substances compounding list Industry Update: Interim 503A and 503B Bulks Lists New Revisions BREAKING: The FDA just reversed

2019 Jun Merav Jacobson Bensky, Irit Ayalon-Dangur, Roi Ayalon-Dangur, Eviatar Naamany, Anat Gafter-Gvili, Gideon Koren, Shachaf Shiber

Use local knee injection when: - You have a specific, localized injury (torn ACL, MCL sprain, patellar tendinopathy, meniscus tear) - Pain concentrates in one area of the knee - You can identify the approximate location of the damaged structure Use systemic injection when: - You have diffuse knee pain without a clear source - Multiple structures are involved (post-surgical, advanced osteoarthritis) - You are stacking BPC-157 with TB-500 for broader systemic repair - You cannot tolerate injections near the knee Split protocol: Some users inject 60-70% of their daily dose locally near the knee and the remaining 30-40% subcutaneously in the abdomen

7 Musculoskeletal Recovery BPC 157 is increasingly popular among athletes and individuals with musculoskeletal injuries due to its potential benefits in this area

Ian Cook investigates If you tell your neurologist you are taking vitamins to treat your multiple sclerosis (MS) you are likely to be met with scepticism or worse